Gene Therapy Shows Promise for Age-Related Macular Degeneration Reduced treatment burden, durable therapeutic effects with aflibercept-expressing construct Jul 15, 2022
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
C5 Inhibitor Slows Geographic Atrophy in Dry Macular Degeneration Progression slowed by 27-30% at 12 and 18 months with avacincaptad versus sham control Oct 13, 2021
Bispecific Antibody Compares Favorably With Anti-VEGF for Retinal Disease Similar visual acuity and safety with potential for extended dosing interval Oct 13, 2021
Continuous-Release Anti-VEGF for Macular Degeneration Continues to Impress Implant matches monthly injections for efficacy with 6-month refill schedule Oct 13, 2021
Adverse Events Halt Gene Therapy Trial for Diabetic Macular Edema Three cases of irreversible vision loss, high rate of intraocular inflammation Oct 12, 2021
Early Steroid Switch May Improve Visual Acuity for Some DME Patients Significant improvement in vision, retinal thickening after inadequate response to anti-VEGF Oct 11, 2021
Face Masks May Risk Bacterial Spread to Eyes During Intravitreal Injections No clear link to endophthalmitis after ophthalmologic procedure -- yet Oct 10, 2021
Device Extends Treatment Interval for AMD Refill with anti-VEGF therapy pushed to 15 months Jul 26, 2018
New Drugs Show Promise in Retinopathy Bi-specific antibody, integrin inhibitor move to phase III Jul 26, 2018
Benefits with Early Treatment of Diabetic Retinopathy Studies make case for targeting high-risk nonproliferative disease Jul 25, 2018
More Frequent Anti-VEGF Therapy, Better Vision Consistent vision gain with seven or more injections per year Jul 23, 2018
Is Syringe Lubricant Causing Floaters After Eye Injection? Complaints after bevacizumab injections may be due to syringe design Aug 15, 2017
Steroid Implants Slow Diabetic Retinopathy Fluocinolone acetonide implants deliver continuous micro-dose Aug 13, 2017
